Search - tctmd.com

Displaying 381 - 400 of 640

Sort: Relevancy | Date

Presentation TVT 2019

Feasibility of Repeat Transcatheter Aortic Valve Replacement (TAVR) After Sapien 3 TAVR (TAV-in-TAV): A Pilot Angiographic Study

Presenter: Gilbert Tang

June 13, 2019

Presentation TVT 2019

Diabetes Mellitus: Is There a True Paradoxical Clinical Outcome After AVR?

Presenter: Rashad Belin

June 13, 2019

Presentation TVT 2019

Transcatheter Aortic Valve-in-Valve in Patients With Previous Homograft

Presenter: Karim Al-Azizi

June 13, 2019

Presentation TVT 2019

Outcomes of Transcatheter Aortic Valve Replacement (TAVR) for Mixed Aortic Valve Disease: Results From the TVT Registry

Presenter: Bhaskar Bhardwaj

June 13, 2019

Presentation TVT 2019

Rationalizing the Cost Effectiveness of Cerebral Protection During TAVR

Presenter: Hemal Gada

June 13, 2019

Presentation TVT 2019

Selective Use — Is There a Middle Ground?

Presenter: Jeffrey Moses

June 13, 2019

Presentation TVT 2019

Not Necessary — Soft Data and Excessive Costs!

Presenter: David Muller

June 13, 2019

Presentation TVT 2019

Systematic — In All Patients, Whenever Possible!

Presenter: Nicolas Van Mieghem

June 13, 2019

Presentation TVT 2019

Cerebral Embolic Protection for TAVR With TriGuard 3: Updates From the REFLECT Clinical Trial

Presenter: Tamim Nazif

June 13, 2019

Presentation TVT 2019

Comprehensive Review of the Sentinel Cerebral Embolic Protection Program

Presenter: Julia Seeger

June 13, 2019

Presentation TVT 2019

The PARTNER 3 Low-Risk Randomized Trial

Presenter: Susheel Kodali

June 13, 2019

Presentation TVT 2019

The Evolut Low-Risk Randomized Trial

Presenter: Steven Yakubov

June 13, 2019

Presentation TVT 2019

Successful BASILICA for a Failed CoreValve

Presenter: Ikki Komatsu

June 13, 2019

Presentation TVT 2019

Percutaneous Aortic Valve Replacement: Life-Threatening Complication and Out-of-the-Box Solution

Presenter: Nagendra Chouhan

June 13, 2019

Presentation TVT 2019

Controversies Around PPM: Its Estimation and When Does it Matter?

Presenter: Philippe Pibarot

June 13, 2019

Presentation TVT 2019

Status Updates on the Next Generation of Cerebral Protection Devices

Presenter: Giora Weisz

June 13, 2019

Presentation TVT 2019

Incidence, Trends, Risk Factors, and Comparison With Surgery for Early Stroke After TAVR: Reports From PARTNER and the TVT Registry (in High- and Intermediate-Risk Patients)

Presenter: Samir Kapadia

June 13, 2019

Presentation TVT 2019

Do We Need a Randomized Trial of VIV vs. Redo SAVR for Failed Bioprosthetic Surgical Valves? The REPEAT Trial

Presenter: Vinayak Bapat

June 13, 2019

Presentation TVT 2019

Splitting Leaflets. BASILICA to Reduce the Risk of Coronary Obstruction During VIV (and Other TAVR) Procedures

Presenter: Danny Dvir

June 13, 2019

Presentation TVT 2019

How to Screen for Risk of Coronary Obstruction Risk on CT Prior to Aortic Valve-in-Valve Procedures

Presenter: Philipp Blanke

June 13, 2019

Advertisement

Feasibility of Repeat Transcatheter Aortic Valve Replacement (TAVR) After Sapien 3 TAVR (TAV-in-TAV): A Pilot Angiographic Study

Diabetes Mellitus: Is There a True Paradoxical Clinical Outcome After AVR?

Transcatheter Aortic Valve-in-Valve in Patients With Previous Homograft

Outcomes of Transcatheter Aortic Valve Replacement (TAVR) for Mixed Aortic Valve Disease: Results From the TVT Registry

Rationalizing the Cost Effectiveness of Cerebral Protection During TAVR

Selective Use — Is There a Middle Ground?

Not Necessary — Soft Data and Excessive Costs!

Systematic — In All Patients, Whenever Possible!

Cerebral Embolic Protection for TAVR With TriGuard 3: Updates From the REFLECT Clinical Trial

Comprehensive Review of the Sentinel Cerebral Embolic Protection Program

The PARTNER 3 Low-Risk Randomized Trial

The Evolut Low-Risk Randomized Trial

Successful BASILICA for a Failed CoreValve

Percutaneous Aortic Valve Replacement: Life-Threatening Complication and Out-of-the-Box Solution

Controversies Around PPM: Its Estimation and When Does it Matter?

Status Updates on the Next Generation of Cerebral Protection Devices

Incidence, Trends, Risk Factors, and Comparison With Surgery for Early Stroke After TAVR: Reports From PARTNER and the TVT Registry (in High- and Intermediate-Risk Patients)

Do We Need a Randomized Trial of VIV vs. Redo SAVR for Failed Bioprosthetic Surgical Valves? The REPEAT Trial

Splitting Leaflets. BASILICA to Reduce the Risk of Coronary Obstruction During VIV (and Other TAVR) Procedures

How to Screen for Risk of Coronary Obstruction Risk on CT Prior to Aortic Valve-in-Valve Procedures

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content